Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: VIATRIS INC · Firm: VIATRIS INC.
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund; Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; School Access to Emergency Epinephrine; Biosimilars; H.R. 8 The American Taxpayer Relief Act; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.214 - Preserve Access to Affordable Generics ActS.504 - Fair and Immediate Release of Generic Drugs Act H.R.933 - Consolidated and Further Continuing Appropriations Act, 2013 S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients' Access to Treatments Act of 2013 S.CON.RES.8 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. FY 2014 Budget, FY 2013 Budget, Generic Drug User Fees, Biosimilar User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY13 Presidential Budget Request
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2013 · second_quarter · 2A
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via
Source: Senate LDA
Safeguarding America's Pharmaceuticals Act of 2013
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund; Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; School Access to Emergency Epinephrine; Biosimilars; H.R. 8 The American Taxpayer Relief Act; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.214 - Preserve Access to Affordable Generics ActS.504 - Fair and Immediate Release of Generic Drugs Act H.R.933 - Consolidated and Further Continuing Appropriations Act, 2013 S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients' Access to Treatments Act of 2013 S.CON.RES.8 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. FY 2014 Budget, FY 2013 Budget, Generic Drug User Fees, Biosimilar User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY13 Presidential Budget Request
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund; Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; School Access to Emergency Epinephrine; Biosimilars; H.R. 8 The American Taxpayer Relief Act; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.214 - Preserve Access to Affordable Generics ActS.504 - Fair and Immediate Release of Generic Drugs Act H.R.933 - Consolidated and Further Continuing Appropriations Act, 2013 S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients' Access to Treatments Act of 2013 S.CON.RES.8 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. FY 2014 Budget, FY 2013 Budget, Generic Drug User Fees, Biosimilar User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY13 Presidential Budget Request
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund; Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; School Access to Emergency Epinephrine; Biosimilars; H.R. 8 The American Taxpayer Relief Act; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.214 - Preserve Access to Affordable Generics ActS.504 - Fair and Immediate Release of Generic Drugs Act H.R.933 - Consolidated and Further Continuing Appropriations Act, 2013 S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients' Access to Treatments Act of 2013 S.CON.RES.8 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. FY 2014 Budget, FY 2013 Budget, Generic Drug User Fees, Biosimilar User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY13 Presidential Budget Request
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund; Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; School Access to Emergency Epinephrine; Biosimilars; H.R. 8 The American Taxpayer Relief Act; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.214 - Preserve Access to Affordable Generics ActS.504 - Fair and Immediate Release of Generic Drugs Act H.R.933 - Consolidated and Further Continuing Appropriations Act, 2013 S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients' Access to Treatments Act of 2013 S.CON.RES.8 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. FY 2014 Budget, FY 2013 Budget, Generic Drug User Fees, Biosimilar User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY13 Presidential Budget Request
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Quality, Security, and Accountability Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Quality, Security, and Accountability Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund; Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; School Access to Emergency Epinephrine; Biosimilars; H.R. 8 The American Taxpayer Relief Act; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.214 - Preserve Access to Affordable Generics ActS.504 - Fair and Immediate Release of Generic Drugs Act H.R.933 - Consolidated and Further Continuing Appropriations Act, 2013 S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients' Access to Treatments Act of 2013 S.CON.RES.8 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. FY 2014 Budget, FY 2013 Budget, Generic Drug User Fees, Biosimilar User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY13 Presidential Budget Request
H.R. 3627/S. 1884, School Access to Emergency Epinephrine Act; S. 3187, Food and Drug Administration Safety and Innovation Act (FDASIA), Title 3, Generic Drug User Fee Amendment (GDUFA), Title 4, Fees Relating to Biosimilar Biological Products; Pharmaceutical Distribution Supply Chain; HIV/AIDS; Patent Settlements; Biosimilars; Electronic Distribution of Labeling of Prescription Drugs
S 1884 (School Access to Emergency Epinephrine); HR 6433 FDA User Fee Correction Act; Patent settlements; Serialization; Issues related to HIV/AIDS: Funding for antiretrovirals, PEPFAR, Global Fund, FDA; Issues related to biogenerics; Issues related to the generic drug industry
2013 · second_quarter · Q2
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Q1
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund; Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; School Access to Emergency Epinephrine; Biosimilars; H.R. 8 The American Taxpayer Relief Act; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.214 - Preserve Access to Affordable Generics ActS.504 - Fair and Immediate Release of Generic Drugs Act H.R.933 - Consolidated and Further Continuing Appropriations Act, 2013 S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients' Access to Treatments Act of 2013 S.CON.RES.8 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. FY 2014 Budget, FY 2013 Budget, Generic Drug User Fees, Biosimilar User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY13 Presidential Budget Request
Filing targets: Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Q4
H.R. 3627/S. 1884, School Access to Emergency Epinephrine Act; S. 3187, Food and Drug Administration Safety and Innovation Act (FDASIA), Title 3, Generic Drug User Fee Amendment (GDUFA), Title 4, Fees Relating to Biosimilar Biological Products; Pharmaceutical Distribution Supply Chain; HIV/AIDS; Patent Settlements; Biosimilars; Electronic Distribution of Labeling of Prescription Drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Q3
S 1884 (School Access to Emergency Epinephrine); HR 6433 FDA User Fee Correction Act; Patent settlements; Serialization; Issues related to HIV/AIDS: Funding for antiretrovirals, PEPFAR, Global Fund, FDA; Issues related to biogenerics; Issues related to the generic drug industry
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE